Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis

Ashly E. Jordan, David C. Perlman, Joshua Neurer, Daniel J. Smith, Don Des Jarlais, Holly Hagan

Research output: Contribution to journalArticle

Abstract

Since 2000, an increase in hepatitis C virus infection among HIV-infected (HIV+) men who have sex with men has been observed. Evidence points to blood exposure during sex as the medium of hepatitis C virus transmission. Hepatitis C virus prevalence among HIV + MSM overall and in relation to injection drug use is poorly characterized. In this study, a systematic review and meta-analysis examining global hepatitis C virus antibody prevalence and estimating active hepatitis C virus prevalence among HIV + MSM were conducted; 42 reports provided anti-hepatitis C virus prevalence data among HIV + MSM. Pooled prevalence produced an overall anti-hepatitis C virus prevalence among HIV + MSM of 8.1%; active HCV prevalence estimate was 5.3%–7.3%. Anti-hepatitis C virus prevalence among injection drug use and non-injection drug use HIV + MSM was 40.0% and 6.7%, respectively. Among HIV + MSM, hepatitis C virus prevalence increased significantly over time among the overall and non-injection drug use groups, and decreased significantly among injection drug use HIV + MSM. We identified a moderate prevalence of hepatitis C virus among all HIV + MSM and among non-injection drug use HIV + MSM; for both, prevalence was observed to be increasing slightly. Pooled prevalence of hepatitis C virus among HIV + MSM was higher than that observed in the 1945–1965 US birth cohort. The modest but rising hepatitis C virus prevalence among HIV + MSM suggests an opportunity to control HCV among HIV + MSM; this combined with data demonstrating a rising hepatitis C virus incidence highlights the temporal urgency to do so.

Original languageEnglish (US)
Pages (from-to)145-159
Number of pages15
JournalInternational Journal of STD and AIDS
Volume28
Issue number2
DOIs
StatePublished - 2017

Fingerprint

Virus Diseases
Hepacivirus
Meta-Analysis
HIV
Pharmaceutical Preparations
Injections
Hepatitis C Antibodies

Keywords

  • hepatitis C virus infection
  • HIV/AIDS
  • HIV/HCV co-infection
  • Men who have sex with men
  • meta-analysis
  • systematic review

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Prevalence of hepatitis C virus infection among HIV+ men who have sex with men : a systematic review and meta-analysis. / Jordan, Ashly E.; Perlman, David C.; Neurer, Joshua; Smith, Daniel J.; Des Jarlais, Don; Hagan, Holly.

In: International Journal of STD and AIDS, Vol. 28, No. 2, 2017, p. 145-159.

Research output: Contribution to journalArticle

@article{1014e8b8d64d452a92e0d32704895626,
title = "Prevalence of hepatitis C virus infection among HIV+ men who have sex with men: a systematic review and meta-analysis",
abstract = "Since 2000, an increase in hepatitis C virus infection among HIV-infected (HIV+) men who have sex with men has been observed. Evidence points to blood exposure during sex as the medium of hepatitis C virus transmission. Hepatitis C virus prevalence among HIV + MSM overall and in relation to injection drug use is poorly characterized. In this study, a systematic review and meta-analysis examining global hepatitis C virus antibody prevalence and estimating active hepatitis C virus prevalence among HIV + MSM were conducted; 42 reports provided anti-hepatitis C virus prevalence data among HIV + MSM. Pooled prevalence produced an overall anti-hepatitis C virus prevalence among HIV + MSM of 8.1{\%}; active HCV prevalence estimate was 5.3{\%}–7.3{\%}. Anti-hepatitis C virus prevalence among injection drug use and non-injection drug use HIV + MSM was 40.0{\%} and 6.7{\%}, respectively. Among HIV + MSM, hepatitis C virus prevalence increased significantly over time among the overall and non-injection drug use groups, and decreased significantly among injection drug use HIV + MSM. We identified a moderate prevalence of hepatitis C virus among all HIV + MSM and among non-injection drug use HIV + MSM; for both, prevalence was observed to be increasing slightly. Pooled prevalence of hepatitis C virus among HIV + MSM was higher than that observed in the 1945–1965 US birth cohort. The modest but rising hepatitis C virus prevalence among HIV + MSM suggests an opportunity to control HCV among HIV + MSM; this combined with data demonstrating a rising hepatitis C virus incidence highlights the temporal urgency to do so.",
keywords = "hepatitis C virus infection, HIV/AIDS, HIV/HCV co-infection, Men who have sex with men, meta-analysis, systematic review",
author = "Jordan, {Ashly E.} and Perlman, {David C.} and Joshua Neurer and Smith, {Daniel J.} and {Des Jarlais}, Don and Holly Hagan",
year = "2017",
doi = "10.1177/0956462416630910",
language = "English (US)",
volume = "28",
pages = "145--159",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Prevalence of hepatitis C virus infection among HIV+ men who have sex with men

T2 - a systematic review and meta-analysis

AU - Jordan, Ashly E.

AU - Perlman, David C.

AU - Neurer, Joshua

AU - Smith, Daniel J.

AU - Des Jarlais, Don

AU - Hagan, Holly

PY - 2017

Y1 - 2017

N2 - Since 2000, an increase in hepatitis C virus infection among HIV-infected (HIV+) men who have sex with men has been observed. Evidence points to blood exposure during sex as the medium of hepatitis C virus transmission. Hepatitis C virus prevalence among HIV + MSM overall and in relation to injection drug use is poorly characterized. In this study, a systematic review and meta-analysis examining global hepatitis C virus antibody prevalence and estimating active hepatitis C virus prevalence among HIV + MSM were conducted; 42 reports provided anti-hepatitis C virus prevalence data among HIV + MSM. Pooled prevalence produced an overall anti-hepatitis C virus prevalence among HIV + MSM of 8.1%; active HCV prevalence estimate was 5.3%–7.3%. Anti-hepatitis C virus prevalence among injection drug use and non-injection drug use HIV + MSM was 40.0% and 6.7%, respectively. Among HIV + MSM, hepatitis C virus prevalence increased significantly over time among the overall and non-injection drug use groups, and decreased significantly among injection drug use HIV + MSM. We identified a moderate prevalence of hepatitis C virus among all HIV + MSM and among non-injection drug use HIV + MSM; for both, prevalence was observed to be increasing slightly. Pooled prevalence of hepatitis C virus among HIV + MSM was higher than that observed in the 1945–1965 US birth cohort. The modest but rising hepatitis C virus prevalence among HIV + MSM suggests an opportunity to control HCV among HIV + MSM; this combined with data demonstrating a rising hepatitis C virus incidence highlights the temporal urgency to do so.

AB - Since 2000, an increase in hepatitis C virus infection among HIV-infected (HIV+) men who have sex with men has been observed. Evidence points to blood exposure during sex as the medium of hepatitis C virus transmission. Hepatitis C virus prevalence among HIV + MSM overall and in relation to injection drug use is poorly characterized. In this study, a systematic review and meta-analysis examining global hepatitis C virus antibody prevalence and estimating active hepatitis C virus prevalence among HIV + MSM were conducted; 42 reports provided anti-hepatitis C virus prevalence data among HIV + MSM. Pooled prevalence produced an overall anti-hepatitis C virus prevalence among HIV + MSM of 8.1%; active HCV prevalence estimate was 5.3%–7.3%. Anti-hepatitis C virus prevalence among injection drug use and non-injection drug use HIV + MSM was 40.0% and 6.7%, respectively. Among HIV + MSM, hepatitis C virus prevalence increased significantly over time among the overall and non-injection drug use groups, and decreased significantly among injection drug use HIV + MSM. We identified a moderate prevalence of hepatitis C virus among all HIV + MSM and among non-injection drug use HIV + MSM; for both, prevalence was observed to be increasing slightly. Pooled prevalence of hepatitis C virus among HIV + MSM was higher than that observed in the 1945–1965 US birth cohort. The modest but rising hepatitis C virus prevalence among HIV + MSM suggests an opportunity to control HCV among HIV + MSM; this combined with data demonstrating a rising hepatitis C virus incidence highlights the temporal urgency to do so.

KW - hepatitis C virus infection

KW - HIV/AIDS

KW - HIV/HCV co-infection

KW - Men who have sex with men

KW - meta-analysis

KW - systematic review

UR - http://www.scopus.com/inward/record.url?scp=85011589311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011589311&partnerID=8YFLogxK

U2 - 10.1177/0956462416630910

DO - 10.1177/0956462416630910

M3 - Article

C2 - 26826159

AN - SCOPUS:85011589311

VL - 28

SP - 145

EP - 159

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 2

ER -